COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma

Schadendorf, Dirk; Dummer, Reinhard; Flaherty, Keith T.; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B.; Garbe, Claus; Gogas, Helen J.; Gutzmer, Ralf; Krajsova, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandala, Mario; Yamazaki, Naoya; Queirolo, Paola; Guenzel, Carolin; Polli, Anna; Thakur, Mahgull; di Pietro, Alessandra; Ascierto, Paolo A.

dc.contributor.author	Garbe, Claus
dc.date.accessioned	2025-01-20T11:20:23Z
dc.date.available	2025-01-20T11:20:23Z
dc.date.issued	2024
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10900/160285
dc.language.iso	en	de_DE
dc.publisher	London : Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2024.114073	de_DE
dc.subject.ddc	610	de_DE
dc.title	COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_01617
utue.personen.roh	Schadendorf, Dirk
utue.personen.roh	Dummer, Reinhard
utue.personen.roh	Flaherty, Keith T.
utue.personen.roh	Robert, Caroline
utue.personen.roh	Arance, Ana
utue.personen.roh	de Groot, Jan Willem B.
utue.personen.roh	Garbe, Claus
utue.personen.roh	Gogas, Helen J.
utue.personen.roh	Gutzmer, Ralf
utue.personen.roh	Krajsova, Ivana
utue.personen.roh	Liszkay, Gabriella
utue.personen.roh	Loquai, Carmen
utue.personen.roh	Mandala, Mario
utue.personen.roh	Yamazaki, Naoya
utue.personen.roh	Queirolo, Paola
utue.personen.roh	Guenzel, Carolin
utue.personen.roh	Polli, Anna
utue.personen.roh	Thakur, Mahgull
utue.personen.roh	di Pietro, Alessandra
utue.personen.roh	Ascierto, Paolo A.
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article 114073	de_DE
dcterms.isPartOf.ZS-Volume	204	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE